Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurence Booth

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Oncotarget|March 17, 2016
Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROSMehrad Tavallai, Laurence Booth, Jane L Roberts, et al.
Aging|July 12, 2021
Inhibition of heat shock proteins increases autophagosome formation, and reduces the expression of APP, Tau, SOD1 G93A and TDP-43Paul Dent, Laurence Booth, Jane L Roberts, et al.
Journal of Cellular Physiology|January 9, 2020
Neratinib degrades MST4 via autophagy that reduces membrane stiffness and is essential for the inactivation of PI3K, ERK1/2, and YAP/TAZ signalingPaul Dent, Laurence Booth, Andrew Poklepovic, et al.
The Journal of Dermatological Treatment|May 5, 2020
A novel plant-derived compound is synergistic with 5-fluorouracil and has increased apoptotic activity through autophagy in the treatment of actinic keratosesCameron E West, Shawn G Kwatra, Justin Choi, et al.
Cancer Biology & Therapy|December 9, 2014
Regulation of dimethyl-fumarate toxicity by proteasome inhibitorsLaurence Booth, Nichola Cruickshanks, Seyedmehrad Tavallai, et al.
Aging|October 13, 2022
AR12 increases BAG3 expression which is essential for Tau and APP degradation via LC3-associated phagocytosis and macroautophagyPaul Dent, Laurence Booth, Jane L Roberts, et al.
Oncotarget|February 2, 2017
The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivoLaurence Booth, Jane L Roberts, Cindy Sander, et al.
Biochemical Pharmacology|June 2, 2021
Osimertinib-resistant NSCLC cells activate ERBB2 and YAP/TAZ and are killed by neratinibPaul Dent, Laurence Booth, Andrew Poklepovic, et al.
Cancer Biology & Therapy|September 30, 2015
Celecoxib enhances [sorafenib + sildenafil] lethality in cancer cells and reverts platinum chemotherapy resistanceTimothy Webb, Jori Carter, Jane L Roberts, et al.
Oncotarget|June 4, 2016
Multi-kinase inhibitors interact with sildenafil and ERBB1/2/4 inhibitors to kill tumor cells in vitro and in vivoLaurence Booth, Thomas Albers, Jane L Roberts, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Oncotarget|March 17, 2016
Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROSMehrad Tavallai, Laurence Booth, Jane L Roberts, et al.
Aging|July 12, 2021
Inhibition of heat shock proteins increases autophagosome formation, and reduces the expression of APP, Tau, SOD1 G93A and TDP-43Paul Dent, Laurence Booth, Jane L Roberts, et al.
Journal of Cellular Physiology|January 9, 2020
Neratinib degrades MST4 via autophagy that reduces membrane stiffness and is essential for the inactivation of PI3K, ERK1/2, and YAP/TAZ signalingPaul Dent, Laurence Booth, Andrew Poklepovic, et al.
The Journal of Dermatological Treatment|May 5, 2020
A novel plant-derived compound is synergistic with 5-fluorouracil and has increased apoptotic activity through autophagy in the treatment of actinic keratosesCameron E West, Shawn G Kwatra, Justin Choi, et al.
Cancer Biology & Therapy|December 9, 2014
Regulation of dimethyl-fumarate toxicity by proteasome inhibitorsLaurence Booth, Nichola Cruickshanks, Seyedmehrad Tavallai, et al.
Aging|October 13, 2022
AR12 increases BAG3 expression which is essential for Tau and APP degradation via LC3-associated phagocytosis and macroautophagyPaul Dent, Laurence Booth, Jane L Roberts, et al.
Oncotarget|February 2, 2017
The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivoLaurence Booth, Jane L Roberts, Cindy Sander, et al.
Biochemical Pharmacology|June 2, 2021
Osimertinib-resistant NSCLC cells activate ERBB2 and YAP/TAZ and are killed by neratinibPaul Dent, Laurence Booth, Andrew Poklepovic, et al.
Cancer Biology & Therapy|September 30, 2015
Celecoxib enhances [sorafenib + sildenafil] lethality in cancer cells and reverts platinum chemotherapy resistanceTimothy Webb, Jori Carter, Jane L Roberts, et al.
Oncotarget|June 4, 2016
Multi-kinase inhibitors interact with sildenafil and ERBB1/2/4 inhibitors to kill tumor cells in vitro and in vivoLaurence Booth, Thomas Albers, Jane L Roberts, et al.
Pageof 10